GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 310 participants.
Also called NCT06578741
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 310 participants
- Sponsor
- Registry
-
NCT06578741
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06578741. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-25 (actual); primary completion 2027-06-25 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
- Condition
- Abdominal Aortic Aneurysm
- Condition
- Pararenal Aortic Aneurysm
- Condition
- Thoracoabdominal Aortic Aneurysm
- Intervention (Device)
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct06578741- Content hash
547db46cbdd5438a722fd4f04dbcda2e3c9be10d85bcac72529c462cace88795